[
    [
        {
            "time": "2020-10-23",
            "original_text": "Remdesivir Gets FDA Approval. What It Means for Gilead Stock and Vaccine Makers.",
            "features": {
                "keywords": [
                    "Remdesivir",
                    "FDA",
                    "Approval",
                    "Gilead",
                    "Vaccine"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Remdesivir Gets FDA Approval. What It Means for Gilead Stock and Vaccine Makers.",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-10-23",
            "original_text": "Remdesivir ‘is not a knock out punch’ but it does help patients ‘recover quicker’: doctor",
            "features": {
                "keywords": [
                    "Remdesivir",
                    "patients",
                    "recover",
                    "doctor"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Remdesivir ‘is not a knock out punch’ but it does help patients ‘recover quicker’: doctor",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-10-23",
            "original_text": "Pharmaceutical companies ‘are doing a good job’ with efficacy and transparency: physician",
            "features": {
                "keywords": [
                    "Pharmaceutical",
                    "efficacy",
                    "transparency",
                    "physician"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Pharmaceutical companies ‘are doing a good job’ with efficacy and transparency: physician",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-10-23",
            "original_text": "Roche (RHHBY) Inks Deal to Develop Oral Coronavirus Treatment",
            "features": {
                "keywords": [
                    "Roche",
                    "Oral",
                    "Coronavirus",
                    "Treatment"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Roche (RHHBY) Inks Deal to Develop Oral Coronavirus Treatment",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-10-23",
            "original_text": "Benzinga's Top Upgrades, Downgrades For October 23, 2020",
            "features": {
                "keywords": [
                    "Upgrades",
                    "Downgrades",
                    "October",
                    "2020"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "Benzinga's Top Upgrades, Downgrades For October 23, 2020",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2020-10-23",
            "original_text": "New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status",
            "features": {
                "keywords": [
                    "Jardiance",
                    "cardio-renal",
                    "outcomes",
                    "heart",
                    "failure",
                    "chronic",
                    "kidney",
                    "disease"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-10-23",
            "original_text": "Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus",
            "features": {
                "keywords": [
                    "Healthcare",
                    "Q3",
                    "Earnings",
                    "Growth",
                    "ETFs"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]